Nanomedicine is a branch of medicine using nanotechnology to prevent and treat diseases.
Nanotechnology represents one of the most effective approaches in elevating a drug's …

Ocular diseases profoundly impact patients' vision and overall quality of life globally.
However, effective ocular drug delivery presents formidable challenges within clinical …

Bioactive compound intervention of dry eye disease has been considered as a promising
approach due to the lower adverse reactions. In this study, layer-by-layer oral-deliverable …

Tissue‐specific delivery of oligonucleotide therapeutics beyond the liver remains a key
challenge in nucleic acid drug development. To address this issue, exploiting exosomes as …

Extracellular vesicles (EVs) are nanoscale membrane vesicles of various sizes that can be
secreted by most cells. EVs contain a diverse array of cargo, including RNAs, lipids …

Neovascular age-related macular degeneration (AMD), a leading cause of blindness,
requires frequent intravitreal injection of antivascular endothelial growth factor (anti-VEGF) …

Changing positions of amino acid residues in the peptide sequence alters the peptide's
assembly behaviors, affording various nanostructures. However, it remains elusive that how …

Posterior segment eye diseases present a challenge in treatment due to the complex
structures in the eye that serve as robust static and dynamic barriers, limiting the penetration …

Dry eye disease (DED) is a prevalent ocular disorder characterized by unstable tear film
condition with loss of aqueous or mucin, excessive oxidative stress, and inflammation …

Dry eye disease is a multifactorial disorder of the eye and tear film with potential damage to
the ocular surface. Various treatment approaches for this disorder aim to alleviate disease …